SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - Biochemical …, 2020 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …
被引用次数：143 相关文章

SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

L Wu, AM O'Kane, H Peng, Y Bi… - Biochemical …, 2020 - hero.epa.gov
Abstract The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …

SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.

L Wu, AM O'Kane, H Peng, Y Bi… - Biochemical …, 2020 - europepmc.org
ABSTRACT The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …
[HTML] nih.gov

[HTML][HTML] SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

L Wu, AM O'Kane, H Peng, Y Bi… - Biochemical …, 2020 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …

SARS-CoV-2 and cardiovascular complications: from molecular mechanisms to pharmaceutical management.

L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - 2020 - cabidigitallibrary.org
Abstract The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of …
[PDF] u-bordeaux.fr

[PDF][PDF] SARS-CoV-2 and Cardiovascular Complications: from Molecular 2 Mechanisms to Pharmaceutical Management

L Wu, AM O'Kane, H Peng, Y Bi, D Motriuk-Smith… - umfcs.u-bordeaux.fr
24 ABSTRACT 25 The coronavirus disease 2019 (COVID-19), elicited by severe acute
respiratory syndrome 26 coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health …

SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management

L Wu, AM O'Kane, H Peng, Y Bi… - Biochemical …, 2020 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of global …

SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management.

L Wu, AM O'Kane, H Peng, Y Bi… - Biochemical …, 2020 - europepmc.org
The coronavirus disease 2019 (COVID-19), elicited by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, is a pandemic public health emergency of global …